サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1754038

ニュートリゲノミクス市場レポート：製品、サンプルタイプ、用途、エンドユーザー、地域別、2025年～2033年

Nutrigenomics Market Report by Product, Sample Type, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.80円
ニュートリゲノミクス市場レポート：製品、サンプルタイプ、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ニュートリゲノミクスの世界市場規模は2024年に13億4,000万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに31億7,100万米ドルに達し、2025年から2033年の間に10％の成長率（CAGR）を示すと予測しています。遺伝子と食事の相互作用およびそれらが健康全般に及ぼす影響に対する意識の高まりが市場を刺激しています。

ニュートリゲノミクス市場分析：

  • 主な市場促進要因：消費者の栄養ニーズに対応する遺伝子検査サービスの利用可能性の増加が市場を後押ししています。
  • 主要市場動向：個人の健康目標に沿ったウェルネスソリューションに対する需要の高まりが、同市場におけるオーダーメイドの栄養オプションに拍車をかけています。
  • 競合情勢：主な市場企業には、BASF SE、Cell-Logic、Cura Integrative Medicine、Danone S.A、Fagron、Genova Diagnostics、Holistic Health International、Koninklijke DSM N.V.、Metagenics Inc.、Nutrigenomix Inc.、Xcode Lifeなどがあります。
  • 地理的動向：高度なヘルスケアインフラが北米市場を押し上げています。また、健康とフィットネスに対する消費者の志向の高まりが、アジア太平洋地域の市場を活性化しています。このほか、遺伝子研究への旺盛な投資が欧州市場の見通しを高めています。このほか、広範な研究開発活動がラテンアメリカの市場をさらに拡大しています。
  • 課題と機会：標準化されたガイドラインの欠如が市場の妨げとなっています。しかし、遺伝子データの解釈と個別化された食事推奨のための研究開発の増加は、予測期間を通じて市場を活性化し続けると思われます。

ニュートリゲノミクス市場動向：

個別化栄養ソリューションに対する需要の高まり

ニュートリゲノミクスは、個人の遺伝的体質に基づいてパーソナライズされた食事を作成し、健康の最適化と疾病の予防に役立てるためにますます使用されるようになっています。このアプローチは、一般化された栄養計画からシフトし、より良い結果を得るために独自の生物学的ニーズに沿ったオーダーメイドのソリューションを提供します。例えば、2024年8月、Avesthagen社とApollo AyurVAID社は提携して「AvestaAyurVAID」を立ち上げ、アーユルヴェーダとニュートリゲノミクスを統合し、個別化医療食品と栄養補助食品を開発しました。この提携は、慢性疾患に対する特定の栄養ニーズに対応し、科学的に検証された植物由来のソリューションを推進することで、積極的な健康管理を目指すものです。ニュートリゲノミクス市場予測レポートによると、これは重要な成長促進要因として作用しています。

AIと遺伝子データの統合

AIと遺伝子解析を組み合わせることで、より正確で実用的な栄養推奨が可能になります。AIは、大規模なデータセットを分析することで、複雑な遺伝子と食事の相互作用を理解するのに役立ち、それによって、パーソナライズされた食事の変更を通じて健康を改善するためのより正確な介入を可能にします。例えば、2024年7月、ヴィエルーツ・ウェルネス・ソリューションズは、AIと遺伝子科学を組み合わせ、ニュートリゲノミクスに基づいてパーソナライズされたウェルネス・プランを提供するEPLIMOプログラムを発表しました。この取り組みでは、遺伝子データを利用して食事、サプリメント、ライフスタイルの変化を提案し、疾病リスクの低減と最適な健康状態の促進を目指します。これがニュートリゲノミクス市場の需要を高めています。

慢性疾患管理への注目の高まり

ニュートリゲノミクスは、疾病リスクを軽減できる栄養計画を提供することで、慢性疾患の管理に重要な役割を果たしています。さらに、個別化された食事は、糖尿病、心血管疾患、肥満などの問題に対処するための重要なツールとなりつつあり、個人に合わせた栄養戦略を通じて、これらの症状をより効果的に管理するのに役立っています。例えば、2024年8月には、若者の精密栄養を促進するため、遺伝子に関する知見と食育の統合に焦点を当てたGENEYプログラムが開始されました。このイニシアチブは、学校におけるニュートリゲノミクスの認知度を高め、生徒により健康的なライフスタイルの選択を促すことで、肥満と非伝染性疾患に対処することを目的としています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のニュートリゲノミクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 試薬とキット
  • サービス

第7章 市場内訳：サンプルタイプ別

  • 唾液
  • 頬粘膜スワブ
  • 血液
  • その他

第8章 市場内訳：用途別

  • 心血管疾患
  • 肥満
  • がん調査
  • その他

第9章 市場内訳：エンドユーザー別

  • 栄養士
  • スポーツクリニック
  • 企業向けプログラム
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BASF SE
    • Cell-Logic
    • Cura Integrative Medicine
    • Danone S.A
    • Fagron
    • Genova Diagnostics
    • Holistic Health International
    • Koninklijke DSM N.V.
    • Metagenics Inc.
    • Nutrigenomix Inc.
    • Xcode Life
図表

List of Figures

  • Figure 1: Global: Nutrigenomics Market: Major Drivers and Challenges
  • Figure 2: Global: Nutrigenomics Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Nutrigenomics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Nutrigenomics Market: Breakup by Sample Type (in %), 2024
  • Figure 6: Global: Nutrigenomics Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Nutrigenomics Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Nutrigenomics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Nutrigenomics (Reagents and Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Nutrigenomics (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Nutrigenomics (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Nutrigenomics (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Nutrigenomics (Saliva) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Nutrigenomics (Saliva) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Nutrigenomics (Buccal Swab) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Nutrigenomics (Buccal Swab) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Nutrigenomics (Blood) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Nutrigenomics (Blood) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Nutrigenomics (Other Sample Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Nutrigenomics (Other Sample Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Nutrigenomics (Cardiovascular Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Nutrigenomics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Nutrigenomics (Obesity) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Nutrigenomics (Obesity) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Nutrigenomics (Cancer Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Nutrigenomics (Cancer Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Nutrigenomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Nutrigenomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Nutrigenomics (Dieticians) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Nutrigenomics (Dieticians) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Nutrigenomics (Sport Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Nutrigenomics (Sport Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Nutrigenomics (Corporate Programs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Nutrigenomics (Corporate Programs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Nutrigenomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Nutrigenomics Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Nutrigenomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Nutrigenomics Industry: SWOT Analysis
  • Figure 85: Global: Nutrigenomics Industry: Value Chain Analysis
  • Figure 86: Global: Nutrigenomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nutrigenomics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Nutrigenomics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Nutrigenomics Market Forecast: Breakup by Sample Type (in Million USD), 2025-2033
  • Table 4: Global: Nutrigenomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Nutrigenomics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Nutrigenomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Nutrigenomics Market: Competitive Structure
  • Table 8: Global: Nutrigenomics Market: Key Players
目次
Product Code: SR112025A6568

The global nutrigenomics market size reached USD 1,340 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,171 Million by 2033, exhibiting a growth rate (CAGR) of 10% during 2025-2033. The growing awareness about gene-diet interactions and their impact on overall health is stimulating the market.

Nutrigenomics Market Analysis:

  • Major Market Drivers: Increased availability of genetic testing services catering to consumer's nutritional needs is propelling the market.
  • Key Market Trends: The rising demand for wellness solutions that align with individual health goals is fueling tailored nutrition options in the market.
  • Competitive Landscape: Some of the major market companies include BASF SE, Cell-Logic, Cura Integrative Medicine, Danone S.A, Fagron, Genova Diagnostics, Holistic Health International, Koninklijke DSM N.V., Metagenics Inc., Nutrigenomix Inc., and Xcode Life, among many others.
  • Geographical Trends: Advanced healthcare infrastructure is elevating the market in North America. Moreover, the increasing consumer inclination toward health and fitness is fueling the market in Asia Pacific. Besides this, strong investments in genetic research are enhancing the market outlook in Europe. Besides this, extensive R&D activities are further augmenting the market in Latin America.
  • Challenges and Opportunities: The lack of standardized guidelines is hindering the market. However, increased research and development for interpreting genetic data and making personalized dietary recommendations will continue to catalyze the market over the forecasted period.

Nutrigenomics Market Trends:

Growing Demand for Personalized Nutrition Solutions

Nutrigenomics is increasingly used to create personalized diets based on an individual's genetic makeup, helping to optimize health and prevent disease. This approach shifts away from generalized nutrition plans, offering tailored solutions that align with unique biological needs for better outcomes. For instance, in August 2024, Avesthagen and Apollo AyurVAID partnered to launch "AvestaAyurVAID," integrating Ayurveda with nutrigenomics to create personalized medical foods and dietary supplements. This collaboration aims to address specific nutritional needs for chronic diseases, promoting scientifically validated, plant-based solutions for proactive health management. According to the nutrigenomics market forecast report, this is acting as a significant growth-inducing factor.

Integration of AI and Genetic Data

The combination of AI and genetic analysis allows for more accurate and actionable nutritional recommendations. AI helps in understanding complex gene-diet interactions by analyzing large datasets, thereby enabling more precise interventions for improving health through personalized dietary changes. For instance, in July 2024, Vieroots Wellness Solutions introduced the EPLIMO program, combining AI and genetic science to offer personalized wellness plans based on nutrigenomics. This initiative uses genetic data to suggest diet, supplements, and lifestyle changes, aiming to reduce disease risks and promote optimal health. This is escalating the nutrigenomics market demand.

Increased Focus on Chronic Disease Management

Nutrigenomics plays a crucial role in managing chronic conditions by offering targeted nutrition plans that can mitigate disease risks. Moreover, personalized diets are becoming a key tool in addressing issues like diabetes, cardiovascular disease, and obesity, helping individuals manage these conditions more effectively through tailored nutritional strategies. For instance, in August 2024, the GENEY program was launched to promote precision nutrition among youth, focusing on integrating genetic insights with dietary education. The initiative aims to address obesity and non-communicable diseases by fostering awareness of nutrigenomics in schools and encouraging healthier lifestyle choices among students.

Global Nutrigenomics Industry Segmentation:

Breakup by Product:

  • Reagents and Kits
  • Services

Nutrigenomics reagents and kits and services support genetic testing and analysis for personalized nutrition. These products help identify gene-diet interactions, enabling tailored dietary recommendations. In addition, services often include genetic profiling, data interpretation, and personalized wellness plans to optimize health through nutrition based on individual genetic markers. This is expanding the nutrigenomics market outlook.

Breakup by Sample Type:

  • Saliva
  • Buccal Swab
  • Blood
  • Others

Nutrigenomics uses various sample types, such as saliva, buccal swabs, and blood, to analyze genetic data. Saliva and buccal swabs are non-invasive methods, while blood provides more detailed genomic information. These samples help create personalized nutrition plans based on genetic profiles to optimize health outcomes. This is escalating the nutrigenomics market share.

Breakup by Application:

  • Cardiovascular Diseases
  • Obesity
  • Cancer Research
  • Others

Nutrigenomics studies the relationship between genetics and diet, focusing on how individual genetic variations influence the risk of cardiovascular diseases, obesity, and cancer, thereby enabling personalized nutritional interventions for improved health outcomes.

Breakup by End User:

  • Dieticians
  • Sport Clinics
  • Corporate Programs
  • Others

As per the nutrigenomics market outlook report, dieticians play a vital role in tailoring dietary plans based on genetic profiles, enhancing health outcomes. In contrast, sport clinics leverage this approach to optimize athletic performance, while corporate programs focus on personalized nutrition for employee wellness and productivity.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

As per the nutrigenomics market analysis report, in Asia Pacific, the market is growing rapidly due to increasing health awareness and rising disposable incomes. In contrast, Europe emphasizes personalized nutrition regulations and research initiatives, while North America leads in technological advancements and consumer adoption. Apart from this, Latin America shows potential with growing interest in wellness, and the Middle East and Africa are expanding, driven by rising obesity rates and healthcare investments.

Competitive Landscape:

The nutrigenomics market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

  • BASF SE
  • Cell-Logic
  • Cura Integrative Medicine
  • Danone S.A
  • Fagron
  • Genova Diagnostics
  • Holistic Health International
  • Koninklijke DSM N.V.
  • Metagenics Inc.
  • Nutrigenomix Inc.
  • Xcode Life

Key Questions Answered in This Report:

  • How has the global nutrigenomics market performed so far, and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nutrigenomics market growth?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the sample type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nutrigenomics market, and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nutrigenomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Sample Type

  • 7.1 Saliva
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Buccal Swab
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Blood
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cardiovascular Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Obesity
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cancer Research
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Dieticians
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Sport Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Corporate Programs
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 BASF SE
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cell-Logic
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Cura Integrative Medicine
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Danone S.A
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Fagron
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Genova Diagnostics
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Holistic Health International
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Metagenics Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Nutrigenomix Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Xcode Life
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio